
FEMY Valuation
Femasys Inc
FEMY Relative Valuation
FEMY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FEMY is overvalued; if below, it's undervalued.
Historical Valuation
Femasys Inc (FEMY) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.64 is considered Undervalued compared with the five-year average of -2.18. The fair price of Femasys Inc (FEMY) is between 2.96 to 4.22 according to relative valuation methord. Compared to the current price of 0.64 USD , Femasys Inc is Undervalued By 78.45%.
Relative Value
Fair Zone
2.96-4.22
Current Price:0.64
78.45%
Undervalued
-1.55
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Femasys Inc. (FEMY) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-1.86
EV/EBIT
Femasys Inc. (FEMY) has a current EV/EBIT of -1.86. The 5-year average EV/EBIT is -1.00. The thresholds are as follows: Strongly Undervalued below -4.84, Undervalued between -4.84 and -2.92, Fairly Valued between 0.92 and -2.92, Overvalued between 0.92 and 2.84, and Strongly Overvalued above 2.84. The current Forward EV/EBIT of -1.86 falls within the Historic Trend Line -Fairly Valued range.
0.64
PS
Femasys Inc. (FEMY) has a current PS of 0.64. The 5-year average PS is 14.83. The thresholds are as follows: Strongly Undervalued below -22.86, Undervalued between -22.86 and -4.02, Fairly Valued between 33.68 and -4.02, Overvalued between 33.68 and 52.53, and Strongly Overvalued above 52.53. The current Forward PS of 0.64 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Femasys Inc. (FEMY) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.07. The thresholds are as follows: Strongly Undervalued below -5.18, Undervalued between -5.18 and -3.12, Fairly Valued between 0.99 and -3.12, Overvalued between 0.99 and 3.05, and Strongly Overvalued above 3.05. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-1.71
P/FCF
Femasys Inc. (FEMY) has a current P/FCF of -1.71. The 5-year average P/FCF is -1.99. The thresholds are as follows: Strongly Undervalued below -5.62, Undervalued between -5.62 and -3.81, Fairly Valued between -0.18 and -3.81, Overvalued between -0.18 and 1.64, and Strongly Overvalued above 1.64. The current Forward P/FCF of -1.71 falls within the Historic Trend Line -Fairly Valued range.
Femasys Inc (FEMY) has a current Price-to-Book (P/B) ratio of 13.77. Compared to its 3-year average P/B ratio of 4.20 , the current P/B ratio is approximately 227.89% higher. Relative to its 5-year average P/B ratio of 3.36, the current P/B ratio is about 309.35% higher. Femasys Inc (FEMY) has a Forward Free Cash Flow (FCF) yield of approximately -74.35%. Compared to its 3-year average FCF yield of -78.13%, the current FCF yield is approximately -4.84% lower. Relative to its 5-year average FCF yield of -62.93% , the current FCF yield is about 18.14% lower.
13.77
P/B
Median3y
4.20
Median5y
3.36
-74.35
FCF Yield
Median3y
-78.13
Median5y
-62.93
Competitors Valuation Multiple
The average P/S ratio for FEMY's competitors is 3.40, providing a benchmark for relative valuation. Femasys Inc Corp (FEMY) exhibits a P/S ratio of 0.64, which is -81.28% above the industry average. Given its robust revenue growth of 84.78%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of FEMY decreased by 43.12% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 221.48K to 409.27K.
The secondary factor is the Margin Expansion, contributed -47.02%to the performance.
Overall, the performance of FEMY in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

CODX
Co-Diagnostics Inc
0.460
USD
-1.71%

LVTX
LAVA Therapeutics NV
1.625
USD
-0.31%

NRSN
Neurosense Therapeutics Ltd
1.120
USD
+8.21%

MXC
Mexco Energy Corp
9.200
USD
+2.22%

TRT
Trio-Tech International
7.380
USD
-4.53%

ENLV
Enlivex Therapeutics Ltd
1.050
USD
0.00%

UTSI
UTStarcom Holdings Corp
2.500
USD
-2.34%

LGVN
Longeveron Inc
0.834
USD
-0.48%

KFFB
Kentucky First Federal Bancorp
4.020
USD
+1.77%
FAQ
Is Femasys Inc (FEMY) currently overvalued or undervalued?
Femasys Inc (FEMY) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.64 is considered Undervalued compared with the five-year average of -2.18. The fair price of Femasys Inc (FEMY) is between 2.96 to 4.22 according to relative valuation methord. Compared to the current price of 0.64 USD , Femasys Inc is Undervalued By 78.45% .







